At the largest hospital in Brooklyn, doctors are working to address disparities for patients facing advanced heart failure.

In addition to improving heart failure symptoms, finerenone reduced the onset of new type 2 diabetes in patients with mildly ...

“I would certainly consider using finerenone,” Bloom, heart failure cardiologist and system director of the Cardio-Oncology Program at NYU Langone Health in New York, said in an email.

Dr. Maya Barghash, MD works in New York, NY as an Advanced Heart Failure & Transplant Cardiologist and has 15 years experience. They graduated from New York University in 2009. Dr. Barghash ...

The incidence rate of heart failure was 2- to 3-fold higher ... University's Mailman School of Public Health in New York City. Heart failure is a leading cause of death among people with type ...

The designation is for AB-1002 (also known as NAN-101) as a one-shot therapy for adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) class III heart failure symptoms ...

and New York Heart Association (NYHA) class. In total, 655 patients were recruited from 87 centers in 26 countries. The median age was 76.5 years and 92.5% were male. More than three-quarters (77. ...

Inspra (eplerenone tablets; Pfizer, Inc., New York, NY) is an aldosterone blocker ... and clinical evidence of congestive heart failure after an acute myocardial infarction" (based on a letter ...

More than 62,000 seniors in Western New York will benefit from three measures discussed during a visit to Buffalo on Monday by U.S. Senate Majority Leader Chuck Schumer.

“I would certainly consider using finerenone,” Bloom, heart failure cardiologist and system director of the Cardio-Oncology Program at NYU Langone Health in New York, said in an email. “However, I ...